Consistent with our cell viability assay, loss of FLASH alone was sufficient to induce apoptosis in pancreatic cancer cells, which was further increased by gemcitabine treatment (Figures 6e and f, FLASH KD vs Mock). This evidence concerns the gene CASP8AP2 and pancreatic neoplasm.